Michael K. Loucks, a nationally recognized health care fraud prosecutor, joined Skadden Arps as a litigation Partner in the Boston office in July 2010. With 25 years in public service, Mr. Loucks most recently served as acting U.S. Attorney and first Assistant U.S. Attorney for the District of Massachusetts, where he led major criminal and civil investigations, as well as many of the most high-profile health care fraud prosecutions of the past two decades.
Since joining Skadden, Mr. Loucks’ practice has focused on representing companies in government criminal investigations, False Claims Act and other civil litigation, regulatory matters with the FDA and the Office of Inspector General, and Foreign Corrupt Practices Act investigations. He has represented U.S. and international pharmaceutical and biotech companies; medical device companies; health maintenance organizations; physician-owned hospitals; an ambulance provider; a seafood processing plant; a publishing company; a genetic testing laboratory and its owners; and a U.S. senator. His government investigation work has involved off-label promotion and anti-kickback issues; alleged violations of the Clean Air Act; and FCPA issues.
While Acting U.S. Attorney and first assistant, he reviewed and approved all major prosecutions and civil matters, including all health and defense False Claims Act matters, all environmental prosecutions, all Armed Export and Control Act (AECA) and major export and embargo-related criminal prosecutions, and all major public corruption prosecutions.
Before serving as Acting U.S. Attorney, Mr. Loucks had a long history in the Massachusetts U.S. Attorney’s Office, where he was First Assistant U.S. Attorney; white collar crime section chief; health care fraud unit chief; and health care fraud coordinator.
Mr. Loucks received his B.A. from Harvard College and his J.D. from the University of Virginia.
He is the co-author of the Bloomberg BNA treatise Prosecuting and Defending Health Care Fraud Cases.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)